FNY Investment Advisers’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,376
Closed -$55K 846
2024
Q2
$55K Sell
3,376
-2,874
-46% -$46K 0.04% 238
2024
Q1
$96 Sell
6,250
-27,083
-81% -$429K 0.06% 187
2023
Q4
$544K Buy
33,333
+14,583
+78% +$250K 0.6% 40
2023
Q3
$346K Buy
+18,750
New +$331K 0.21% 69
2023
Q2
Sell
-2,188
Closed -$26K 726
2023
Q1
$26K Buy
+2,188
New +$30.5K 0.03% 241
2018
Q3
Sell
-25
Closed -$8K 1357
2018
Q2
$8K Buy
+25
New +$9.02K ﹤0.01% 508

Other funds holding TECX

FNY Investment Advisers's TECX Position: Q3 2024 in Review

FNY Investment Advisers sold out of Tectonic Therapeutic (TECX) in Q3 2024, closing a stake of 3,376 shares — an estimated $55K sold.

FNY Investment Advisers first reported a position in TECX in Q2 2018 and held it in 6 quarters. The position peaked at $544K in Q4 2023. 53 funds tracked by Wall St. Rank hold TECX as of Q3 2024.

  • FNY Investment Advisers reported no remaining Tectonic Therapeutic position as of Q3 2024 after selling out during the quarter.
  • FNY Investment Advisers sold 3,376 Tectonic Therapeutic shares in Q3 2024, an estimated $55K.
  • FNY Investment Advisers first reported a position in Tectonic Therapeutic in Q2 2018 and held it in 6 quarters.
  • FNY Investment Advisers's Tectonic Therapeutic position peaked at $544K in Q4 2023.
  • 53 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2024.

Based on FNY Investment Advisers's 13F filing for Q3 2024, filed 18 Oct 2024.